KeySine

HealthcareSeries AJinan, China

Latest round

Series A

Last raised

Apr 2025

Total raised

Undisclosed

Investors

2

About KeySine

Established in 2021 and based in Jinan, China, KeySine is a reproductive health service company., Ltd. The company’s main business is addressing unmet clinical needs in reproductive health through innovative medical solutions. The company’s self-developed product portfolio includes tubal interventional therapy systems, uterine infertility treatment devices, and ovarian function restoration technologies. Its products are used in the field of reproductive medicine. KeySine generates revenue by providing advanced medical devices, tailored clinical solutions, and technology licensing partnerships to healthcare institutions.

Who invested in KeySine

2 investors across 1 round

See all investors in KeySine

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Apr 18, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about KeySine

Who invested in KeySine?

KeySine has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has KeySine raised?

KeySine has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did KeySine last raise money?

KeySine's most recent round on record is a Series A, in Apr 2025.

What does KeySine do?

Established in 2021 and based in Jinan, China, KeySine is a reproductive health service company.

Where is KeySine headquartered?

KeySine is headquartered in Jinan, China.

Which VCs invest in companies like KeySine?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at KeySine's stage. Their profiles are linked below.

Raising like KeySine? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.